Actinium Pharmaceuticals Inc (NYSEAMERICAN: ATNM) stock closed at $5.31 on 12/22/23 after a major increase of 10.9%. Moreover, above average trading volume at 137% of normal accompanied the advance. The stock has risen 4.3% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
ATNM’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
Actinium Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Actinium Pharmaceuticals has a very low Appreciation Score of 5 and a very low Power Rating of 2, triggering the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment